- Home
- JELD vs ZVRA Comparison
JELD vs ZVRA Comparison
Compare JELD & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JELD
- ZVRA
- Stock Information
- Founded
- JELD 1960
- ZVRA 2006
- Country
- JELD United States
- ZVRA United States
- Employees
- JELD N/A
- ZVRA N/A
- Industry
- JELD Forest Products
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- JELD Basic Materials
- ZVRA Health Care
- Exchange
- JELD Nasdaq
- ZVRA Nasdaq
- Market Cap
- JELD 392.0M
- ZVRA 467.6M
- IPO Year
- JELD 2017
- ZVRA 2015
- Fundamental
- Price
- JELD $4.39
- ZVRA $10.14
- Analyst Decision
- JELD Hold
- ZVRA Strong Buy
- Analyst Count
- JELD 8
- ZVRA 7
- Target Price
- JELD $6.03
- ZVRA $22.57
- AVG Volume (30 Days)
- JELD 986.0K
- ZVRA 1.8M
- Earning Date
- JELD 11-03-2025
- ZVRA 11-05-2025
- Dividend Yield
- JELD N/A
- ZVRA N/A
- EPS Growth
- JELD N/A
- ZVRA N/A
- EPS
- JELD N/A
- ZVRA N/A
- Revenue
- JELD $3,430,185,000.00
- ZVRA $62,020,000.00
- Revenue This Year
- JELD N/A
- ZVRA $336.43
- Revenue Next Year
- JELD $2.44
- ZVRA $54.26
- P/E Ratio
- JELD N/A
- ZVRA N/A
- Revenue Growth
- JELD N/A
- ZVRA 161.81
- 52 Week Low
- JELD $3.27
- ZVRA $6.19
- 52 Week High
- JELD $14.65
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- JELD 38.67
- ZVRA 47.50
- Support Level
- JELD $4.61
- ZVRA $10.56
- Resistance Level
- JELD $4.90
- ZVRA $11.23
- Average True Range (ATR)
- JELD 0.22
- ZVRA 0.55
- MACD
- JELD 0.02
- ZVRA -0.12
- Stochastic Oscillator
- JELD 33.57
- ZVRA 6.41
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.